Combination therapy with mTOR and PI3 kinase inhibitors is broadly synergistic in a wide variety of endometrial cancer cells
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类] 妇产科学
[关键词] PI3K;Akt;mammalian target of rapamycin;temsirolimus;BEZ235;endometrial cancer [时效性]
